CMT Health, headquartered in Singapore and driven by a global vision, stands at the forefront of innovation in drug delivery solutions. With a robust presence across diverse sectors—including hospital acute care, laboratory testing, nursing centers, home care, and veterinary clinics—CMT Health leverages over 20 years of cutting-edge research and development expertise. Our commitment is to deliver safe, efficient, and cost-effective devices to customers around the globe.

Our growth is deeply rooted in a profound understanding of our customers' needs. By partnering with major international hospital systems, we create solutions that are both secure and economically viable. Our comprehensive portfolio is organized into three pivotal areas of drug delivery:

• Safety Fluid Injection :  Advanced solutions for vaccination, nutritional feeding, and diabetes management.
• Safety Specimen Collection :  Precision tools for the collection and processing of blood, urine, and specialized medicinal fluids.
• Safety Infusion Therapy :  Innovative devices for vascular access, encompassing flushing, indwelling, and accessing systems.

In addition, CMT Health extends its expertise to the veterinary sector with a comprehensive portfolio of syringes and needles tailored for livestock, including swine, cattle, and goats. Our innovative devices are playing a crucial role in safeguarding animal health globally.

CMT Health is steadfast in its commitment to environmental, social, and governance (ESG) principles. We prioritize the well-being of our shareholders, employees, suppliers, customers, and the environment, reflecting our dedication to sustainable and responsible practices.

Looking ahead, CMT Health remains resolute in its mission to "CARE MORE TOGETHER" for improved health outcomes worldwide.